Puma Biotechnology | PBYI - PE Price to Earnings


Puma Biotechnology reported 13.93 in PE Price to Earnings for its fiscal quarter ending in June of 2024.





Pe Change Date
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Daiichi Sankyo 20.73 1.74 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Exelixis 602.31 586.25 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
Glaxosmithkline 11.66 0.28 Dec/2025
Incyte 14.84 2.79 Dec/2025
Moderna 27.22 14.51 Jun/2023
Novartis 17.85 2.11 Dec/2025
Pfizer 14.48 5.18 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Takeda 235.05 184.95 Dec/2025
TG Therapeutics 10.76 2.32 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Vertex Pharmaceuticals 26.15 2.22 Dec/2025